Stanford University
Showing 34,601-34,650 of 36,311 Results
-
Chenghan Xie
Ph.D. Student in Management Science and Engineering, admitted Autumn 2024
Current Research and Scholarly InterestsOptimization, theory & practice. Energy-aware AI, nerual-network structure & data center management.
-
James Xie
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor, Clinical InformaticsBioDr. James Xie is a board certified pediatrician, pediatric anesthesiologist, and clinical informaticist at Stanford University School of Medicine. His goal is to improve patient care and promote health equity with health information technologies. Currently he serves as a clinical informaticist and Epic physician builder at Stanford Medicine Children's Health. He holds additional appointments in the Division of Obstetric Anesthesiology and Maternal Health and Division of Clinical Informatics.
Dr. Xie studied computer science and medicine at Stanford University, followed by a combined residency in general pediatrics at Boston Children's Hospital and Boston Medical Center and anesthesiology at Brigham and Women's Hospital. After residency, he completed a fellowship in pediatric anesthesiology at Stanford Children's Health where he subsequently joined the faculty. -
Min Xie
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioCausal inference using natural experiments with focuses on public health policy and medical intervention.
Also work on development economics topics of financial and education intervention.
PhD in economics, Heidelberg University
personal webpage: https://minxie.org -
Peter Xie
Ph.D. Student in Mechanical Engineering, admitted Autumn 2023
BioResearch:
Engineer developing hydrogels for cancer immunotherapies -
Shicong (Mimi) Xie
Basic Life Research Scientist
Current Research and Scholarly InterestsI use 4D imaging to study cell growth and cell cycle progression in epithelial organoid models and in intact mice.
-
Xiaoze Xie
Paul L. and Phyllis Wattis Professor of Art
BioXiaoze Xie received his Master of Fine Art degrees from the Central Academy of Arts & Design in Beijing and the University of North Texas. He has had solo exhibitions at the Scottsdale Museum of Contemporary Art, AZ; Dallas Visual Art Center, TX; Modern Chinese Art Foundation, Gent, Belgium; Charles Cowles Gallery, New York; Gallery Paule Anglim, San Francisco; Nicholas Metivier Gallery, Toronto; China Art Archives and Warehouse, Beijing; Gaain Gallery, Seoul; Devin Borden Hiram Butler Gallery, Houston, TX; among others. He has participated in numerous group exhibitions including Shu: Reinventing Books in Contemporary Chinese Art at the China Institute Gallery in New York and Seattle Asian Art Museum, and the traveling exhibition Regeneration: Contemporary Chinese Art from China and the US. His 2004 solo at Charles Cowles was reviewed in “The New York Times”, “Art in America” and "Art Asia Pacific". More recent shows have been reviewed in “Chicago Tribune”, “The Globe and Mail” and “San Francisco Chronicle”. His work is in the permanent collection of the Museum of Fine Arts, Houston and the Scottsdale Museum of Contemporary Art and the Arizona State University Art Museum. Xie received the Pollock-Krasner Foundation Grant (2003) and artist awards from Phoenix Art Museum (1999) and Dallas Museum of Art (1996). Xie is the Paul L. & Phyllis Wattis Professor of Art at Stanford University.
-
Lin Xin
Postdoctoral Scholar, Physics
BioLin Xin is a Postdoctoral Scholar in the Physics Department at Stanford University. He received his Ph.D. from the Georgia Institute of Technology, following undergraduate studies at Shanghai Jiaotong University. His current research centers on advancing optical control of interactions among laser-cooled atoms, with an eye towards applications in quantum simulation, metrology, and computation. He has developed protocols in quantum optimal control for entanglement-enhanced eigenstates in spinor Bose-Einstein condensates.
-
Lei Xing
Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization
-
Xiaojing Xing
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioXiaojing Xing is a health tech founder and product leader working at the intersection of medicine, business, and technology. She has driven AI-powered innovations across hardware and software—building from MVP to scale at both startups and global tech companies.
At Tencent, she led digital health platforms serving over 30 million users and launched AI tools that empowered 200,000+ physicians. Later, as Chief Product Officer at MindLax, she brought a neurofeedback sleep device from concept to market, growing it to thousands of users through data-driven iteration and user empathy.
Recognized on Forbes 30 Under 30 China, Xiaojing blends product management, global go-to-market strategy, and health innovation expertise. She is currently focused on applying AI to consumer health—creating intelligent, accessible technologies that make wellbeing part of everyday life.
Xiaojing holds degrees from Stanford University School of Medicine, Harvard T.H. Chan School of Public Health, and Peking University Health Science Center. -
Lulu Xing
Affiliate,
BioLulu received her undergraduate degree in Biomedicine from the University of Melbourne in Melbourne, Australia. In December 2016, Lulu was awarded a PhD degree in neuroscience from the Florey Institute of Neuroscience and Mental Health, the University of Melbourne, where she identified a major under-appreciated role for subventricular zone-derived neural precursor cells in the process of myelin regeneration after demyelinating injury. Since late 2016, Lulu worked at Australian Regenerative Medicine Institute, Monash University as a postdoctoral fellow in Dr. Tobias Merson’s group, with a focus on developing mouse models to study the molecular and cellular mechanisms underlying myelination mediated by distinct types of endogenous brain stem cells in health and disease. In particular, Lulu developed a novel mouse model of conditional OPC ablation, which could be adopted in different neurological contexts to further advance our knowledge and understanding of OPC biology. Lulu joined the Petritsch lab in late October 2022 as a research scientist, seeking to understand the role of OPCs in the development of glioma as tumour-initiating cells and how they are regulated by complex interactions with several cell types within the tumour microenvironment, using a combination of transgenic mouse models, advanced imaging techniques and single cell biology approaches.
-
Bo Xiong
Postdoctoral Scholar, Biomedical Informatics
Current Research and Scholarly InterestsAI, Foundation Models, Biomedical Data Science
-
Grace Xiong, MD
Assistant Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Xiong’s research is focused on improving the care and management of patients with subacute and chronic spinal cord injury, improving clinical outcomes in spinal surgery, and improving health access to spinal care.
-
Jiangnan Xiong
Masters Student in Materials Science and Engineering, admitted Autumn 2025
BioI’m a 2025 graduate of New York University, where I studied Chemistry and Mathematics. My academic and research experiences span DNA nanotechnology, Organic Chemistry, and analytical chemistry. Beyond research, I am passionate in traveling and reading.
-
熊剑 (Jian Xiong)
Postdoctoral Scholar, Chemical Engineering
BioI thrive to understand the roles of lysosomes in physiological and pathological conditions. Lysosomes are both degradation compartment and metabolic controlling hub, and dysregulation of lysosomal functions are frequently implicated in a vast number of diseases including neurodegenerative diseases, however, the systematic knowledge of the molecular mechanism by which lysosomal contributes to these diseases is lacking. Ion channels are the primary mediators of neuronal activity, defects in neuronal ion channel activity are linked with many kinds of neurodegenerative diseases. Interestingly, besides typical ion channels that are involved in the neuronal activity, defects in lysosomal ion channels, such as TRPML1, CLN7 and CLC-7 are also implicated in neuropathy. My previous work as Ph.D student in University of Texas MD Anderson Cancer Center focused on regulation of lysosomal function by ion channels and metabolites. I discovered a mechanism of lysosomal Na+ channel regulate mTORC1 activation by regulating lysosomal amino acid accumulation. I also discovered role of glutamine in controlling lysosomal degradation capacity. In the meantime, I developed novel methods to isolate organelles. My ultimate research goal is to understand the key developmental pathways and how alterations in gene sequences and expression contribute to human disease, therefore, I am pursuing independent academic researcher as my career goal. Starting Feb 2022, I work with Dr. Monther Abu-Remaileh at Stanford University on role of lysosomes in neurodegenerative diseases. I use genetics, chemical biology and omics approaches to study lysosome function under various physiological and pathological conditions, especially age-associated neurodegenerative disorders, and monogenic neurodegenerative lysosome storage diseases. In Stanford, I aim to integrate ionic regulation, metabolomic regulation and functional proteomic regulation to systematically understand the biology of lysosome in physiological conditions and pathological conditions.
-
Lei Xiong
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsMy research focuses on develop deep learning methods to
1. Infer macrophage-tumor cells interaction using spatial multi-omics
2. Decipher the cis-regulatory code using a large language models
3. Predict enhancer-promoter interaction
4. Multi-omics integration
5. Build foundational model for single-cell genomics
